Skip to main content
Log in

Association of PTPN22 gene (rs2488457) polymorphism with ulcerative colitis and high levels of PTPN22 mRNA in ulcerative colitis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Our aims were to evaluate protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene polymorphisms in ulcerative colitis (UC) and explore PTPN22 mRNA levels in colonic biopsies of UC patients in central China.

Methods

A total of 165 Chinese UC patients and 300 healthy controls were enrolled in this study. PTPN22 −1123G/C, +1858C/T, and +788G/A polymorphisms were genotyped by PCR-restriction fragment length polymorphism method. PTPN22 mRNA expressions in colonic biopsies and serum C-reactive protein (CRP) levels were determined by quantitative PCR and immunonephelometry, respectively.

Results

The frequency of C carrier was higher in UC patients than in healthy controls (66.7 vs. 53.3 %, P = 0.005, odds ratios = 1.75, 95 % CI 1.18–2.60) and associated with extensive colitis (P = 0.029). PTPN22 mRNA levels were elevated in UC patients than in healthy controls (P < 0.001). Among UC patients, PTPN22 mRNA expression levels were higher in biopsies of inflamed colonic tissue compared with noninflamed tissue (P < 0.001) and were correlated with CRP levels (r = 0.578, P < 0.001). PTPN22 mRNA expression levels were elevated in extensive colitis compared to proctitis (P = 0.008) and to left-sided colitis (P = 0.029) and were higher in moderate and severe disease than in mild disease (P = 0.005).

Conclusions

Our study showed the potential association between PTPN22 −1123G/C polymorphism and UC in central China. PTPN22 mRNA levels were highly expressed in UC, especially in active disease, and were correlated with CRP levels, disease location, and disease severity in UC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434

    Article  PubMed  CAS  Google Scholar 

  2. Behrens TW (2011) Lyp breakdown and autoimmunity. Nat Genet 43:821–822

    Article  PubMed  CAS  Google Scholar 

  3. Zhang J, Zahir N, Jiang Q et al (2011) The autoimmune disease-associated PTPN22 variant promotes calpain-mediated LYP/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 43:902–907

    Article  PubMed  CAS  Google Scholar 

  4. Cloutier JF, Veillette A (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111–121

    Article  PubMed  CAS  Google Scholar 

  5. Wu S, Bottini M, Rickert RC et al (2009) In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation. ChemMedChem 4:440–444

    Article  PubMed  CAS  Google Scholar 

  6. Xie Y, Liu Y, Gong G et al (2008) Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. Bioorg Med Chem Lett 18:2840–2844

    Article  PubMed  CAS  Google Scholar 

  7. Stanford SM, Mustelin TM, Bottini N (2010) Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases. Semin Immunopathol 32:127–136

    Article  PubMed  CAS  Google Scholar 

  8. Dultz G, Matheis N, Dittmar M et al (2009) The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19:143–148

    Article  PubMed  CAS  Google Scholar 

  9. Bottini N, Vang T, Cucca F et al (2006) Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18:207–213

    Article  PubMed  CAS  Google Scholar 

  10. Chung SA, Criswell LA (2007) PTPN22: its role in SLE and autoimmunity. Autoimmunity 40:582–590

    Article  PubMed  CAS  Google Scholar 

  11. Diaz-Gallo LM, Espino-Paisán L, Fransen K et al (2011) Differential association of two PTPN22 coding variants with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 17:2287–2294

    Article  PubMed  Google Scholar 

  12. Kawasaki E, Awata T, Ikegami H et al (2006) Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 140:586–593

    PubMed  Google Scholar 

  13. Liu F, Liu J, Zheng TS et al (2012) The −1123G>C variant of PTPN22 gene promoter is associated with latent autoimmune diabetes in adult Chinese Hans. Cell Biochem Biophys 62:273–279

    Article  PubMed  CAS  Google Scholar 

  14. Huang JJ, Qiu YR, Li HX et al (2012) A PTPN22 promoter polymorphism −1123G>C is associated with RA pathogenesis in Chinese. Rheumatol Int 32:767–771

    Article  PubMed  CAS  Google Scholar 

  15. Feng X, Li YZ, Zhang Y et al (2010) Association of the PTPN22 gene (−1123G>C) polymorphism with rheumatoid arthritis in Chinese patients. Tissue Antigens 76:297–300

    Article  PubMed  CAS  Google Scholar 

  16. Orrú V, Tsai SJ, Rueda B et al (2009) A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 18:569–579

    Article  PubMed  Google Scholar 

  17. Rodríguez-Rodríguez L, Taib WR, Topless R et al (2011) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case–control samples. Arthritis Rheum 63:365–372

    Article  PubMed  Google Scholar 

  18. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6

    Article  PubMed  CAS  Google Scholar 

  19. Satsangi J, Silverberg MS, Vermeire S et al (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753

    Article  PubMed  CAS  Google Scholar 

  20. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2:1041–1048

    Article  PubMed  CAS  Google Scholar 

  21. Chang HH, Tai TS, Lu B et al (2012) PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis. PLoS One 7:e33067

    Article  PubMed  CAS  Google Scholar 

  22. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108

    Article  PubMed  CAS  Google Scholar 

  23. Inoue A, Takahashi KA, Arai Y et al (2006) The therapeutic effects of basic fibroblast growth factor contained in gelatin hydrogel microspheres on experimental osteoarthritis in the rabbit knee. Arthritis Rheum 54:264–270

    Article  PubMed  CAS  Google Scholar 

  24. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI et al (2011) Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis 17:963–970

    Article  PubMed  Google Scholar 

  25. Viken MK, Olsson M, Flåm ST et al (2007) The PTPN22 promoter polymorphism −1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 70:190–197

    Article  PubMed  CAS  Google Scholar 

  26. Jostins L, Ripke S, Weersma RK et al (2012) Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124

    Article  PubMed  CAS  Google Scholar 

  27. Mori M, Yamada R, Kobayashi K et al (2005) Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 50:264–266

    Article  PubMed  Google Scholar 

  28. Ronninger M, Guo Y, Shchetynsky K et al (2012) The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls. Genome Med 4:2

    Article  PubMed  CAS  Google Scholar 

  29. Wu J, Katrekar A, Honigberg LA et al (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem 281:11002–11010

    Article  PubMed  CAS  Google Scholar 

  30. Jüliger S, Bongartz M, Luty AJ et al (2003) Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 54:675–680

    PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by grants from the Bureau of Public Health of Wuhan (WX12C34).

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Z., Zhang, H., Xia, B. et al. Association of PTPN22 gene (rs2488457) polymorphism with ulcerative colitis and high levels of PTPN22 mRNA in ulcerative colitis. Int J Colorectal Dis 28, 1351–1358 (2013). https://doi.org/10.1007/s00384-013-1671-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-013-1671-3

Keywords

Navigation